Michael Ploug

Michael Ploug

Group leader

ORCID: 0000-0003-2215-4265

Publication year:
All
1 - 10 out of 10Page size: 10
  1. 2015
  2. Published

    New 177-lutetium labeled urokinase-type plasminogen activator receptor binding peptide conjugate, useful for treating cancer such as colorectal cancer, prostate cancer, neuroendocrine tumors, brain tumors, breast tumors and ovarian tumors

    Kjær, Andreas, Persson, M. & Ploug, Michael, 8 Jul 2015, IPC No. C07K 16/ 30 A I, Patent No. CN104768573, Priority date 3 May 2013, Priority No. WO2013DK50126

    Research output: Patent

  3. Published

    Stepping up the tension in uPAR-mediated signaling by integrins

    Ploug, Michael, 2015

    Research output: Other contribution › Net publication - Internet publication › Research

  4. 2010
  5. Published

    INDUCTION AND/OR MAINTENANCE OF TUMOR DORMANCY BY DISRUPTION OF UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-INTEGRIN INTERACTION

    Ossowski, L., Chaurasia, P., Aguirre-Ghiso Julio, A., Zhou, M. & Ploug, Michael, 30 Sep 2010, IPC No. G06G 7/ 60 A I, Patent No. US2010249184, Priority date 17 Mar 2008, Priority No. US20080531502

    Research output: Patent

  6. 2009

  7. PLAUR (Plasminogen activator, urokinase receptor

    Jacobsen, B., Illemann, M. & Ploug, Michael, 2009

    Research output: Other contribution › Net publication - Internet publication › Research › peer-review

  8. 2008

  9. LYPD3 (LY6/PLAUR domain containing 3

    Jacobsen, B. & Ploug, Michael, 2008

    Research output: Other contribution › Net publication - Internet publication › Research › peer-review

  10. 2006
  11. Published

    Peptide antagonists of the human urokinase receptor and method for selecting them

    Ploug, Michael, Oestergaard, S., Holst-Hansen, C., Stephens, R., Danoe, K. & Holm, A., 11 Apr 2006, IPC No. A61K 38/ 00 A N, Patent No. US7026282, Priority date 1 Jul 1999, Priority No. WO1999DK00377

    Research output: Patent

  12. 2004
  13. Published

    IMMUNOASSAYS FOR THE DETECTION OF UROKINASE RECEPTOR FORMS

    Piironen, T., Hoeyer-Hansen, G., Bruenner, N., Ploug, Michael, List, K., Laursen, B., Danoe, K., Liljas, H., Haese, A., Hartwig, H., Toernblom, M. & Gustafsson, O., 18 Nov 2004, IPC No. G06F 19/ 20 A N, Patent No. WO2004099780, Priority date 6 May 2003, Priority No. DK20030000676

    Research output: Patent

  14. 2003
  15. Published

    Urokinase-type plasminogen activator receptor

    Dano, K., Blasi, F., Roldan, Ann, L., Cubellis, Maria, V., Masucci, Maria, T., Appella, E., Schleuning, W-D., Behrendt, N., Ronne, E., Kristensen, P., Pollanen, J., Salonen, E-M., Stephens, Ross, W., Tapiovaara, H., Vaheri, A., Moller Lisbeth, B., Ellis, V., Lund Leif, R., Ploug, M., Pyke, C. & 1 others, Patthy, L., 6 Feb 2003, IPC No. A61K 38/ 00 A N, Patent No. US2003027981, Priority date 8 Jan 2001, Priority No. US20010755109

    Research output: Patent

  16. 1999
  17. Published

    Vectors and methods for recombinant production of uPA-binding fragments of the human urokinase-type plasminogen receptor (uPAR)

    Danoe, K., Blasi, F., Roldan, Ann, L., Cubellis, Maria, V., Masucci, Maria, T., Appella, E., Schleuning, W-D., Behrendt, N., Rønne, E., Kristensen, P., Pollanen, J., Salonen, E-M., Stephens, Ross, W., Tapiovaara, H., Vaheri, A., Moeller, Lisbeth, B., Ellis, V., Lund, Leif, R., Ploug, M., Pyke, C. & 1 others, Patthy, L., 6 Apr 1999, IPC No. A61K 38/ 00 A N, Patent No. US5891664, Priority date 6 Oct 1994, Priority No. US19940319052

    Research output: Patent

  18. 1996

  19. uPA binding sites on domain 2+3 on uPAR and antibodies reactive therewith

    Pessara, U., Weidle, U., Koenig, B., Kohnert, U., Bartke, I., Dano, K., Ploug, Michael & Ellis, V., 10 Jan 1996, IPC No. C12R 1/ 91 A N, Patent No. EP0691350, Priority date 8 Jul 1994, Priority No. DK19940000831

    Research output: Patent

ID: 33978213